New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
09:14 EDTARRY, BIIBArray and BioPharma Biogen to collaborate in inhibitor discovery and development
Array BioPharma (ARRY) announced a collaboration agreement with Biogen (BIIB) for the discovery and development of inhibitors targeting a novel kinase for the treatment of autoimmune disorders. The collaboration target and lead inhibitors were discovered through Array's proprietary Kinase-Directed Phenotypic Screening Platform. Biogen and Array will collaborate on the discovery of the novel kinase inhibitors. Biogen will be responsible for all aspects of clinical development and commercialization. The agreement includes research funding for three years, various milestone payments payable upon achievement of certain development and commercial milestones, and royalties to Array.
News For ARRY;BIIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2014
07:39 EDTBIIBBiogen reinstated with a Neutral at BofA/Merrill
Subscribe for More Information
September 30, 2014
10:49 EDTARRYArray BioPharma management to meet with Piper Jaffray
Subscribe for More Information
September 29, 2014
08:07 EDTARRYPhase 2 trial of binimetinib in NRAS melanoma shows promising clinical activity
Subscribe for More Information
07:26 EDTBIIBInforma Business Information to hold a conference
Subscribe for More Information
September 23, 2014
09:54 EDTARRYArray BioPharma management to meet with Jefferies
Subscribe for More Information
September 22, 2014
07:21 EDTBIIBEBD Group to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use